Brian J. Caveney, M.D., serves as the Executive Vice President and President of Early Development, as well as the Chief Medical and Scientific Officer at Labcorp Holdings Inc. In this role, Dr. Caveney leads the company's efforts in early-stage drug development, overseeing a wide range of services from clinical trials to companion diagnostics. His leadership is instrumental in driving innovation and ensuring that Labcorp remains at the forefront of the life sciences industry. Dr. Caveney's professional background is marked by significant achievements in both clinical practice and scientific research. Prior to joining Labcorp, he held various leadership positions in the healthcare and pharmaceutical sectors, where he developed a deep understanding of the challenges and opportunities in drug development. His expertise in medical affairs and clinical development has been pivotal in advancing Labcorp's capabilities in personalized medicine and precision oncology. Dr. Caveney's contributions to the field have been recognized through numerous publications and presentations at leading scientific conferences. As the Chief Medical and Scientific Officer, Dr. Caveney plays a crucial role in shaping Labcorp's strategic direction, particularly in the areas of medical and scientific innovation. He works closely with cross-functional teams to integrate cutting-edge technologies and methodologies into the company's service offerings. Under his guidance, Labcorp has expanded its early development services, enhancing its ability to support biopharmaceutical companies in bringing new therapies to market more efficiently and effectively. Dr. Caveney's vision and leadership continue to drive Labcorp's mission to improve health and improve lives.